Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keiko Asakawa
Observed name:
K. Asakawa
Institution:
Statistics Canada
Observed institutions:
Canada's Drug Agency,
Statistics Canada,
University of Alberta,
Public Health Agency of Canada,
Canadian Partnership Against Cancer,
Government of Canada,
Institute of Health Economics
show all 7
OpenAlex ID:
A5091084416
The OncoSim Model: Development and Use for Better Decision-Making in Canadian Cancer Control
2017
·
Cindy L. Gauvreau
, N. R. Fitzgerald
, et al.
·
Current Oncology
·
41
PDF
QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique
2010
·
Scott D Grosse
, Lisa A Prosser
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
41
Canadian Cancer Risk Management Model: Evaluation of Cancer Control
2013
·
William K. Evans
, Michael C. Wolfson
, et al.
·
International Journal of Technology Assessment in Health Care
·
38
Do the determinants of health differ between people living in the community and in institutions?
2009
·
Keiko Asakawa
, David Feeny
, et al.
·
Social Science & Medicine
·
33
Health Utilities Index Mark 3 showed valid in Alzheimer Disease, arthritis, and cataracts
2008
·
Keiko Asakawa
, Darryl Rolfson
, et al.
·
Journal of Clinical Epidemiology
·
27
Trajectories of health-related quality of life differ by age among adults: Results from an eight-year longitudinal study
2011
·
Keiko Asakawa
, Ambikaipakan Senthilselvan
, et al.
·
Journal of Health Economics
·
26
Estimates of future cancer mortality attributable to modifiable risk factors in Canada
2021
·
Joy Pader
, Yibing Ruan
, et al.
·
Canadian Journal of Public Health
·
15
The OncoSim-Breast Cancer Microsimulation Model
2022
·
J.H.E. Yong
, C. Nadeau
, et al.
·
Current Oncology
·
13
PDF
Estimating the future cancer management costs attributable to modifiable risk factors in Canada
2021
·
Yibing Ruan
, Abbey E. Poirier
, et al.
·
Canadian Journal of Public Health
·
13
Using the Cancer Risk Management Model to Evaluate the Health and Economic Impacts of Cytology Compared with Human Papillomavirus DNA Testing for Primary Cervical Cancer Screening in Canada
2016
·
C. Popadiuk
, C.L. Gauvreau
, et al.
·
Current Oncology
·
11
PDF
Evaluation of the natural history of cancer of the cervix, implications for prevention. The Cancer Risk Management Model (CRMM) – Human papillomavirus and cervical components
2015
·
Anthony B. Miller
, Steve Gribble
, et al.
·
Journal of Cancer Policy
·
11
PDF
The Evaluation of Cancer Control Interventions in Lung Cancer using the Canadian Cancer Risk Management Model
2012
·
William K Evans
, Michael Wolfson
, et al.
·
Lung Cancer Management
·
10
Strategies for handling normality assumptions in multi-level modeling: a case study estimating trajectories of Health Utilities Index Mark 3 scores.
2011
·
Julie Bernier
, Yan Feng
, et al.
·
PubMed
·
10
Evaluating Clinical and Cost Impacts of Achieving 90% HPV Vaccination Rate Against Cervical Cancer in Canada Using the OncoSim Cancer Simulation Model
2018
·
N. Fitzgerald
, S. Hussain
, et al.
·
Journal of Global Oncology
·
2
Projection of Body Mass Index (BMI), Chronic Conditions and Healthcare Costs in Canada: An Application of Microsimulation
2013
·
Claude Nadeau
, Keiko Asakawa
, et al.
·
Canadian Journal of Diabetes
·
1
Construct Validity of the Health Utilities Index Mark 3 (HUI3): Alzheimer Disease, Arthritis and Cataract
2006
·
Keiko Asakawa
, David Feeny
·
1
Canadian Oncology Simulation Model(OncoSim)を用いた子宮頸がん政策の評価分析
2021
·
Keiko Asakawa
·
日本計算機統計学会大会論文集
The OncoSim Cancer Simulation Platform: A Tool to Project the Population Effects of Cancer Control Interventions in Canada
2018
·
N. Fitzgerald
, C. Gauvreau
, et al.
·
Journal of Global Oncology
Impacts of Canadian Task Force on Preventive Health (Ctfph) Guidelines “Cytology” Versus American Society Clinical Oncology (ASCO) HPV Guidelines “HPV” for Cervical Cancer Screening
2018
·
Catherine Popadiuk
, Cindy Gauvreau
, et al.
·
Journal of Obstetrics and Gynaecology Canada
Public Health Analytics: A Visual Aid to Interpret the Evidence-Base of Proven Actions on Obesity in the Context of What Needs to be Achieved by Policy
2013
·
Ronald Wall
, Christina Bancej
, et al.
·
Canadian Journal of Diabetes
PDF
Determinants of Health of People Living in the Community and Institutions
2007
·
Keiko Asakawa
, David Feeny
, et al.
·
SSRN Electronic Journal
Does the Same Determinants of Health Model Apply to the Community and Institutional Residents
2006
·
Keiko Asakawa
, David Feeny
Generalizability of the Multiplicative Multi-attribute Utility Function for the Health Utilities Index Mark 3 System
2006
·
Keiko Asakawa
, David Feeny
Show more works
View as search
Works count:
23
Citation count:
293
H-index:
11
I10-index:
13
Year
Topic
Type